Form Bio | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Form Bio

BRIEF

published on 06/27/2024 at 15:05, 4 months 23 days ago

Form Bio et PacBio s'associent pour améliorer les normes de conception et d'analyse des AAV

Collaboration Thérapie Génique Standardisation AAV Ressources
BRIEF

published on 06/27/2024 at 15:05, 4 months 23 days ago

Form Bio and PacBio Partner to Enhance AAV Design and Analysis Standards

Collaboration Gene Therapy Standardization Resources AAV
PRESS RELEASE

published on 06/27/2024 at 15:00, 4 months 23 days ago

Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices
Form Bio and PacBio establish AAV Working Group to standardize practices in AAV research. New initiatives and resources available on AAV Resource Hub

Gene Therapy Form Bio PacBio AAV Working Group AAV Resource Hub
BRIEF

published on 05/07/2024 at 14:05, 6 months 13 days ago

Form Bio lance des tests In Silico pour la conception de vecteurs de thérapie génique

Recherche Et Développement Thérapie Génique Conception De Vecteur Essai In Silico Outil Informatique
BRIEF

published on 05/07/2024 at 14:05, 6 months 13 days ago

Form Bio Launches In Silico Assays for Gene Therapy Vector Design

Research And Development Gene Therapy Vector Design In Silico Assay Computational Tool
PRESS RELEASE

published on 05/07/2024 at 14:00, 6 months 13 days ago

Form Bio Announces In Silico Assays, Enabling Gene Therapy Companies and Their Research Partners to Accelerate the Vector Discovery & Development Process
Form Bio announces the launch of In Silico Assays, empowering gene therapy developers with new capabilities to explore vector designs efficiently and accelerate lead drug candidate development timelines

Gene Therapy Form Bio In Silico Assays Vector Designs Lead Drug Candidates
BRIEF

published on 05/03/2024 at 14:05, 6 months 17 days ago

Form Bio to Showcase AI-Driven AAV Gene Therapy Innovations at ASGCT 2024

Artificial Intelligence Form Bio AAV Gene Therapy ASGCT Pharmaceutical Innovation
BRIEF

published on 05/03/2024 at 14:05, 6 months 17 days ago

Form Bio présentera les innovations en matière de thérapie génique AAV basées sur l'IA à l'ASGCT 2024

Intelligence Artificielle Formulaire Bio ASGCT Thérapie Génique AAV Innovation Pharmaceutique
PRESS RELEASE

published on 05/03/2024 at 14:00, 6 months 17 days ago

Multiple Presentations at ASGCT 2024 Highlight Form Bio’s Expertise in AI-Based AAV Gene Therapy Design and Development
Form Bio to present at ASGCT event on leveraging AI for optimizing gene therapy designs for safety, yield, and efficacy. Sessions include oral presentation, workshop, symposium, and expert meetings

AI Gene Therapy Presentation Form Bio ASGCT
BRIEF

published on 04/18/2024 at 14:05, 7 months 2 days ago

Form Bio annonce la création d'un nouveau conseil consultatif scientifique pour améliorer le développement de thérapies cellulaires et géniques basées sur l'IA

Thérapie Cellulaire Thérapie Génique Formulaire Bio Conseil Consultatif Scientifique Thérapies Basées Sur L'IA

Accesswire

Published on 11/21/2024 at 09:00, 40 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 5 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 15 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 40 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 40 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 39 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 40 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 40 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 25 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 30 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 42 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 42 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 42 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 33 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 20 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE